secwatch.observer — SEC 8-K summary
======================================

Issuer:     Regenerative Medical Technology Group Inc. (RMTG)
CIK:        0001760026
Form:       8-K
Filed at:   2021-08-19T23:59:59+00:00
Accession:  0001213900-21-043755
Event type: m_and_a
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 2.01, 3.02, 5.01, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Meso Numismatics closes Global Stem Cells Group acquisition; renegotiates $10.5M financing
--------------------------------------------------------------------------------

- Acquired all GCSC shares for 1M Series AA Preferred, 8,974 Series DD Preferred, and $225,000 cash.
- Issuance of 1M Series AA Preferred to Benito Novas caused change of control; Novas and CEO jointly control 67% vote.
- Renegotiated June 2021 $10.5M financing: warrant maturity extended to 7 years, locked up for first 2 years.
- $8.2M earmarked for Lans Holdings escrow per prior agreement.
- Entered consulting agreement with ETC (owned by CEO) for 896 Series DD Preferred shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1760026/000121390021043755/0001213900-21-043755-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1760026/000121390021043755/ea146148-8k_mesonumis.htm
  HTML page:      https://secwatch.observer/filing/0001213900-21-043755

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer